Pilot Study of Infrared Imaging of Cutaneous Melanoma

Completed

Conditions studied: Melanoma

In brief

Design: this is a pilot study of infrared imaging of cutaneous lesions in patients and volunteers with and without clinically detectable melanoma, and with one or more palpable cutaneous lesions eligible for this imaging study. Participants will be evaluated with infrared camera imaging at cutaneous sites with known melanoma deposits, suspected melanoma deposits that are to be biopsied, or at cutaneous sites with other lesions, including other skin cancers, benign inflammatory lesions, benign neoplastic lesions (lipomas, epidermal cysts, dermatofibromas, scar, healing wound, etc.).

Key facts

Study ID

NCT00937690

Run by

University of Virginia

People needed

74

Starts

2008-03-01

Last updated by the study team

2014-12-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients or volunteers with or without a history of melanoma.
• One or more palpable skin or subcutaneous lesions for which at least one of the following is true:
• A tissue diagnosis has been made for the lesion(s) in question, by prior cytologic or histologic evaluation (Category A1).
• A tissue diagnosis will be obtained for the lesion(s) in question by cytologic or histologic evaluation (Category A2).
• A tissue diagnosis is not available, but a clinical diagnosis of melanoma or benign lesion is available with a high degree of confidence. Examples are hemangiomas, skin tags, seborrheic keratoses, dermatofibromas, lipomas, or growing pigmented skin lesions that are comparable to other cutaneous metastases of melanoma in the same patient (Category B).
• All patients must have the ability and willingness to give informed consent and must be age 18 years or older at the time of study entry.

You may not qualify if…

• Known or suspected allergy to the adhesive skin markers or water-soluble ink used for the labeling of lesions.
• Very fragile skin that may be susceptible to injury from adhesive markers.
• Patients in whom there is a medical contraindication or potential problem in complying with the requirements of the protocol, in the opinion of the investigator.

Where it is running

• University of Virginia — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.